PRAX
NASDAQ · Biotechnology
Praxis Precision Medicines I
$311.92
+17.27 (+5.86%)
Performance
1D
—
1W
—
1M
—
3M
+15.98%
6M
+495.49%
1Y
+716.76%
YTD
+8.91%
Open$296.81
Previous Close$294.65
Day High$314.00
Day Low$296.81
52W High$335.75
52W Low$26.70
Volume—
Avg Volume433.4K
Market Cap9.09B
P/E Ratio—
EPS$-12.90
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$296.27
Above
SMA 200
$133.67
Above
RSI (14)
61.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
23 analysts
Price Target
-93.8% upside
Current
$311.92
$311.92
Target
$19.45
$19.45
$15.93
$19.45 avg
$25.00
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 13.03M | 1.51B | 1.36B |
| Net Income | -278,552,680 | -397,237,584 | -445,831,143 |
| Profit Margin | -2,137.5% | -26.4% | -32.9% |
| EBITDA | -304,436,703 | -626,558,933 | -546,408,810 |
| Free Cash Flow | — | -309,826,002 | -348,261,984 |
| Rev Growth | — | +19.5% | +13.8% |
| Debt/Equity | — | 0.24 | 0.26 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |